Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
anabolic steroid
|
| gptkbp:administeredBy |
trenbolone acetate
trenbolone enanthate trenbolone hexahydrobenzylcarbonate |
| gptkbp:bannedIn |
gptkb:World_Anti-Doping_Agency
|
| gptkbp:chemicalFormula |
C18H22O2
|
| gptkbp:derivative_of |
gptkb:nandrolone
|
| gptkbp:discoveredBy |
1960s
|
| gptkbp:excretion |
urine
|
| gptkbp:has_anabolic_activity |
yes
|
| gptkbp:has_androgenic_activity |
yes
|
| gptkbp:hasNo |
estrogenic activity
|
| https://www.w3.org/2000/01/rdf-schema#label |
trenbolone
|
| gptkbp:improves |
protein synthesis
nitrogen retention |
| gptkbp:legalStatus |
controlled substance in many countries
|
| gptkbp:marketedAs |
Component T
Finaplix Revalor |
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
270.37 g/mol
|
| gptkbp:not_approved_for |
human use
|
| gptkbp:sideEffect |
hair loss
aggression acne insomnia night sweats increased blood pressure |
| gptkbp:used_in |
cattle implants
|
| gptkbp:usedFor |
gptkb:veterinary_medicine
muscle growth in livestock |
| gptkbp:bfsParent |
gptkb:nandrolone
|
| gptkbp:bfsLayer |
8
|